Publications

    Home       Lab Team      In the News      Publications   Alumni & Former Members      Contact Us
  1. Shelburne, C.E., et al., Serum antibodies to Porphyromonas gingivalis chaperone HtpG predict health in periodontitis susceptible patients. PLoS ONE, 2008. 3(4): p. e1984.
  2. Rios, H.F., et al., Periostin is essential for the integrity and function of the periodontal ligament during occlusal loading in mice. J Periodontol, 2008. 79(8): p. 1480-90.
  3. Preshaw, P.M., et al., Modified-release subantimicrobial dose doxycycline enhances scaling and root planing in subjects with periodontal disease. J Periodontol, 2008. 79(3): p. 440-52.
  4. Lin, Z., et al., Platelet-derived growth factor-B gene delivery sustains gingival fibroblast signal transduction. J Periodontal Res, 2008. 43(4): p. 440-9.
  5. Jin, Q., et al., Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS ONE, 2008. 3(3): p. e1729.
  6. Havens, A.M., et al., Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease. J Periodontol, 2008. 79(5): p. 845-53.
  7. Giannobile, W.V., Host-response therapeutics for periodontal diseases. J Periodontol, 2008. 79(8 Suppl): p. 1592-600.
  8. Cirelli, J.A., et al., AAV2/1-TNFR:Fc gene delivery prevents periodontal disease progression. Gene Ther, 2008.
  9. Wei, G., et al., The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials, 2007. 28(12): p. 2087-96.
  10. Rogers, J.E., et al., Actinobacillus actinomycetemcomitans lipopolysaccharide-mediated experimental bone loss model for aggressive periodontitis. J Periodontol, 2007. 78(3): p. 550-8.
  11. Park, C.H., et al., Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol, 2007. 78(2): p. 273-81.
  12. Needleman, I., et al., A randomized-controlled trial of low-dose doxycycline for periodontitis in smokers. J Clin Periodontol, 2007. 34(4): p. 325-33.
  13. Kirkwood, K.L., et al., Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000, 2007. 43: p. 294-315.
  14. Kinney, J.S., C.A. Ramseier, and W.V. Giannobile, Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci, 2007. 1098: p. 230-51.
  15. Jin, Q., et al., RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol, 2007. 78(7): p. 1300-8.
  16. Herr, A.E., et al., Microfluidic immunoassays as rapid saliva-based clinical diagnostics. Proc Natl Acad Sci U S A, 2007. 104(13): p. 5268-73.
  17. Herr, A.E., et al., Integrated microfluidic platform for oral diagnostics. Ann N Y Acad Sci, 2007. 1098: p. 362-74. 18. Dunn, M.D., et al., Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movement. Bone, 2007. 41(3): p. 446-55.
  18. Dastoor, S.F., et al., Effect of adjunctive systemic azithromycin with periodontal surgery in the treatment of chronic periodontitis in smokers: a pilot study. J Periodontol, 2007. 78(10): p. 1887-96.
  19. Chang, J., et al., Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J Biol Chem, 2007. 282(42): p. 30938-48.
  20. Wei, G., et al., Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release, 2006. 112(1): p. 103-10. 22. Sarment, D.P., et al., Effect of rhPDGF-BB on bone turnover during periodontal repair. J Clin Periodontol, 2006. 33(2): p. 135-40.
  21. Ramseier, C.A., et al., Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am, 2006. 50(2): p. 245-63, ix.
  22. Padbury, A.D., Jr., et al., The impact of primary hyperparathyroidism on the oral cavity. J Clin Endocrinol Metab, 2006. 91(9): p. 3439-45.
  23. Marx, R.E., et al., The first descriptions of bone morphogenetic protein in the dental literature appeared more than a decade ago, yet there is no commercially viable application for this product. Comment on the likelihood that this material will become available to the general dental community and describe those situations in which you see it providing additional benefits to the currently available treatment modalities. Int J Oral Maxillofac Implants, 2006. 21(1): p. 148-53.
  24. Mao, J.J., et al., Craniofacial tissue engineering by stem cells. J Dent Res, 2006. 85(11): p. 966-79.
  25. Kaigler, D., J.A. Cirelli, and W.V. Giannobile, Growth factor delivery for oral and periodontal tissue engineering. Expert Opin Drug Deliv, 2006. 3(5): p. 647-62.
  26. Cooke, J.W., et al., Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng, 2006. 12(6): p. 1441-50.
  27. Williams, R.C., et al., Tissue engineering: what does it mean? Why is it important? Compend Contin Educ Dent, 2005. 26(1): p. 54, 56, 58 passim.
  28. Wang, H.L., et al., Periodontal regeneration. J Periodontol, 2005. 76(9): p. 1601-22.
  29. Taba, M., Jr., et al., Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am, 2005. 49(3): p. 551-71, vi.
  30. Taba, M., Jr., et al., Current concepts in periodontal bioengineering. Orthod Craniofac Res, 2005. 8(4): p. 292-302.
  31. Nevins, M., et al., Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol, 2005. 76(12): p. 2205-15.
  32. Mascarenhas, P., et al., Clinical response of azithromycin as an adjunct to non-surgical periodontal therapy in smokers. J Periodontol, 2005. 76(3): p. 426-36.
  33. Huang, L.H., et al., The effect of platelet-rich plasma on the coronally advanced flap root coverage procedure: a pilot human trial. J Periodontol, 2005. 76(10): p. 1768-77.
  34. Greenwell, H., et al., Oral reconstructive and corrective considerations in periodontal therapy. J Periodontol, 2005. 76(9): p. 1588-600.
  35. Dunn, C.A., et al., BMP gene delivery for alveolar bone engineering at dental implant defects. Mol Ther, 2005. 11(2): p. 294-9.
  36. Zhao, M., et al., Cementoblast delivery for periodontal tissue engineering. J Periodontol, 2004. 75(1): p. 154-61.
  37. Jin, Q.M., et al., Noggin gene delivery inhibits cementoblast-induced mineralization. Connect Tissue Res, 2004. 45(1): p. 50-9.
  38. Jin, Q., et al., Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther, 2004. 9(4): p. 519-26.
  39. Gapski, R., et al., Effect of systemic matrix metalloproteinase inhibition on periodontal wound repair: a proof of concept trial. J Periodontol, 2004. 75(3): p. 441-52.
  40. Anusaksathien, O., et al., Effect of sustained gene delivery of platelet-derived growth factor or its antagonist (PDGF-1308) on tissue-engineered cementum. J Periodontol, 2004. 75(3): p. 429-40.
  41. Oh, T.J., et al., Healing and osseointegration of submerged microtextured oral implants. Clin Oral Implants Res, 2003. 14(5): p. 643-50.
  42. Oh, T.J., et al., Comparative analysis of collagen membranes for the treatment of implant dehiscence defects. Clin Oral Implants Res, 2003. 14(1): p. 80-90.
  43. Jin, Q.M., et al., Cementum engineering with three-dimensional polymer scaffolds. J Biomed Mater Res A, 2003. 67(1): p. 54-60.
  44. Jin, Q.M., et al., Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol, 2003. 74(2): p. 202-13.
  45. Giannobile, W.V. and M.J. Somerman, Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol, 2003. 8(1): p. 193-204.
  46. Giannobile, W.V., K.F. Al-Shammari, and D.P. Sarment, Matrix molecules and growth factors as indicators of periodontal disease activity. Periodontol 2000, 2003. 31: p. 125-34.
  47. Anusaksathien, O., et al., Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng, 2003. 9(4): p. 745-56.
  48. Perez, L.A., et al., Treatment of periodontal disease in a patient with Ehlers-Danlos syndrome. A case report and literature review. J Periodontol, 2002. 73(5): p. 564-70.
  49. Oringer, R.J., et al., Effect of locally delivered minocycline microspheres on markers of bone resorption. J Periodontol, 2002. 73(8): p. 835-42.
  50. Levy, R.M., et al., The effect of apically repositioned flap surgery on clinical parameters and the composition of the subgingival microbiota: 12-month data. Int J Periodontics Restorative Dent, 2002. 22(3): p. 209-19.
  51. Lee, E.J., et al., Comparative histologic analysis of coronally advanced flap with and without collagen membrane for root coverage. J Periodontol, 2002. 73(7): p. 779-88.
  52. Giannobile, W.V., What does the future hold for periodontal tissue engineering? Int J Periodontics Restorative Dent, 2002. 22(1): p. 6-7.
  53. Chen, Q.P. and W.V. Giannobile, Adenoviral gene transfer of PDGF downregulates gas gene product PDGFalphaR and prolongs ERK and Akt/PKB activation. Am J Physiol Cell Physiol, 2002. 282(3): p. C538-44.
  54. Anusaksathien, O. and W.V. Giannobile, Growth factor delivery to re-engineer periodontal tissues. Curr Pharm Biotechnol, 2002. 3(2): p. 129-39.
  55. Zhu, Z., et al., Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J Dent Res, 2001. 80(3): p. 892-7. 
  56. Williams, R.C., et al., Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol, 2001. 72(11): p. 1535-44.
  57. Giannobile, W.V., et al., Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol, 2001. 72(6): p. 815-23.
  58. Al-Shammari, K.F., et al., Effect of non-surgical periodontal therapy on C-telopeptide pyridinoline cross-links (ICTP) and interleukin-1 levels. J Periodontol, 2001. 72(8): p. 1045-51.
  59. Saygin, N.E., et al., Growth factors regulate expression of mineral associated genes in cementoblasts. J Periodontol, 2000. 71(10): p. 1591-600.
  60. Saygin, N.E., W.V. Giannobile, and M.J. Somerman, Molecular and cell biology of cementum. Periodontol 2000, 2000. 24: p. 73-98.
  61. Somerman, M.J., et al., Evolution of periodontal regeneration: from the roots' point of view. J Periodontal Res, 1999. 34(7): p. 420-4.
  62. Levy, R.M., et al., The short-term effect of apically repositioned flap surgery on the composition of the subgingival microbiota. Int J Periodontics Restorative Dent, 1999. 19(6): p. 555-67.
  63. Giannobile, W.V., C-telopeptide pyridinoline cross-links. Sensitive indicators of periodontal tissue destruction. Ann N Y Acad Sci, 1999. 878: p. 404-12.
  64. Palys, M.D., et al., Relationship between C-telopeptide pyridinoline cross-links (ICTP) and putative periodontal pathogens in periodontitis. J Clin Periodontol, 1998. 25(11 Pt 1): p. 865-71. 
  65. Oringer, R.J., et al., C-telopeptide pyridinoline cross-links (ICTP) and periodontal pathogens associated with endosseous oral implants. Clin Oral Implants Res, 1998. 9(6): p. 365-73. 68.
  66. Nevins, M.L., et al., Wound healing around endosseous implants in experimental diabetes. Int J Oral Maxillofac Implants, 1998. 13(5): p. 620-9. 69.
  67. Golub, L.M., et al., Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res, 1998. 12(2): p. 12-26.
  68. Giannobile, W.V., et al., Recombinant human osteogenic protein-1 (OP-1) stimulates periodontal wound healing in class III furcation defects. J Periodontol, 1998. 69(2): p. 129-37.